Methadone versus buprenorphine for inpatient detoxification treatment;Methadon-racemat versus buprenorphin zur stationären entgiftungsbehandlung

Sucht

Volumn 54, Issue 4, 2008, Pages 217-221

  Steinmann, Carsten ^a,b   Artmann, Sissi ^a   Schachtschneider, Annett ^a   Paul, Hans Werner ^a  

^a Inn Salzach Klinikum   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Buprenorphine; Methadone; Opiate detoxification

Indexed keywords

BUPRENORPHINE; METHADONE; OPIATE;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DRUG DETOXIFICATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SYMPTOMATOLOGY; WITHDRAWAL SYNDROME;

EID: 51449108121     PISSN: 09395911     EISSN: None     Source Type: Journal    
DOI: 10.1024/2008.04.03     Document Type: Article

References (6)

1. Bortz, J. & Döring, N. (2002). Forschungs-methoden und Evaluation. Berlin: Springer.
2. Brack J. (2002). Der Einsatz von Buprenorphin in der stationären Entzugsbehandlung. Suchttherapie,3, 205-210.
3. Ebner, R., Schreiber, W. & Zierer, C. (2004). Buprenorphin oder Methadon im Entzug junger Opiatabhängiger? Psychiatrische Praxis, 31, [Supplement 1], 108-110.
4. Gowing, L., Ali, R. & White, J. (2006). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews Issue 2. Art. No.: CD002025. DOI: 10.1002/14651858.CD002025.
5. Seifert, J., Metzner, C., Paetzold, W., Borsutzky, M., Passie, T., Rollnik, J., Wiese, B., Emrich, H. M. & Schneider, U. (2002). Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Pharmacopsychiatry, 35 (5), 159-164.
6. Wesson, D. R. & Ling, W. (2003). The Clinical Opiate Withdrawal Scale (COWS). Journal of psychoactive drugs, 35 (2), 253-259.